Obesity

Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

Early hemodynamic responses to SGLT2i may differ across HF subtypes. In overweight patients with cardiometabolic HFpEF, our preliminary findings suggest an association with reduced vascular resistance, while in HFrEF/HFmrEF, the primary benefit appears to be volume unloading. However, the vascular effects of SGLT2i remain uncertain, and given the small sample size, these results should be interpreted as hypothesis-generating. Our findings also highlight the potential role of non-invasive hemodynamic monitoring in guiding therapy in HF.

Study context

Population
Consecutive heart failure (HF) patients receiving SGLT2i; median age 75 years, 70% overweight/obese, 4 with diabetes; 65% HFpEF, 25% HFmrEF, 10% HFrEFsingle group
Participants
20 patients
Exposure
Baseline vs 4 weeks after SGLT2i start
Outcome
Hemodynamic and echocardiographic changes
Follow-up
Median 33 days [30-68]
Methodological detailssingle-center, preliminary report
  • Single-center
  • Preliminary report

Main finding

As reported in the abstract

Body weight, 67.65 kg [46-99.20] to 65.50 kg [46.30-97]
p = 0.027
Systolic BP, 130 mmHg [100-150] to 116.50 mmHg [100-141]
p = 0.015
Total peripheral resistance index (TPRi), 3616.50 dynes·sec·cm³ [1600-5024] to 3098.50 dynes·sec·cm³ [1608-4684]
p = 0.002
Left atrial volume index, 42.84 ml/m² [27-69.40] to 41.15 ml/m² [26-62.60]
p < 0.001
Peak tricuspid regurgitation velocity, significant decrease
p = 0.023
Pulmonary artery systolic pressure (PASP), 31.0 mmHg (15.0-40.0) vs. 25.50 mmHg (15.0-38.0-)
p = 0.010

Observational data: associations, not effects.

Further findings

Total body water, HFrEF or HFmrEF subgroup

Significant reduction, 66.33 [51.45-74.45] vs. 58.68 [55.13-66.50]

TPRi, HFpEF subgroup (overweight/obese, n = 11, 79%)

Significant reduction, 3681 dynes·sec·cm³ [1600-5024] vs. 3085 dynes·sec·cm³ [1608-4684]
P = 0.005

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report. Cardiovasc Diabetol. Published 26 March 2025. doi:10.1186/s12933-025-02699-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.